Table 1 Demographics
|
Authors (Year, level of evidence) | No of final patients (No of initial patients – losses at follow-up) a | No of patient in the accelerated group (AG) and conservative group (CG) | Sex | Average age (mean ± standard deviation) | Follow-up (months) |
|---|---|---|---|---|---|
|
Arndt et al. [61] (2012, II) | 92 (100–8) |
AG (49) CG (43) | M 34; F 58 | 54.6 ± 9.8 | 16 |
|
Cuff et al. [70] (2012, I) | 68 (68 − 0) |
AG (33) CG (35) |
AG (M 18; F 15) CG (M 20; F 15) |
AG: 54.8 ± 15.9 CG: 56.3 ± 15.6 | 12 |
|
De Roo et al. [110] (2015, I) | 130 (130–0) |
AG (79) CG (51) |
AG (M 48; F 31) CG (M 41; F 10) |
AG: 64.6 ± 10.0 CG: 65.1 ± 9.7 | 4 |
|
Düzgün et al. [71] (2011, II) | 29 (29 − 0) |
AG (13) CG (16) | M 3; F 26 |
AG: 55.9 ± 7.8 CG: 56.6 ± 11 | 4 |
|
Düzgün et al. [29] (2014, II) | 40 (42 − 2) |
AG (19) CG (21) |
AG (M 2; F 17) CG (M 4; F 17) |
AG: 57.7 ± 7.8 CG: 57.2 ± 10.1 | 6 |
|
Jenssen et al. [73] (2018, I) | 118 (120–2) |
AG (60) CG (58) |
AG (M 37; F 23) CG (M 32; F 26) |
AG: 53.8 ± 10.1 CG: 54.3 ± 11.3 | 12 |
|
Keener et al. [63] (2014, I) | 114 (129 − 15) |
AG (61) CG (53) | - |
AG: 54.8 ± 6.3 CG: 55.8 ± 6.3 | 24 |
|
Kim et al. [64] (2012, I) | 105 (117 − 12) |
AG (56) CG (49) |
AG (M 26; F 30) CG (M 18; F 31) |
AG: 60.1 ± 9 CG: 60 ± 10.4 | 12 |
|
Klintberg et al. [72] (2009, II) | 14 (22 − 8) |
AG (7) CG (7) | M 9; F 5 | 53.5 ± 6.9 | 24 |
|
Koh. et al. [77] (2014, I) | 88 (100–12) |
AG (40) CG (48) | M 44; F 44 | 59.9 | 2 |
|
Lee et al. [67] (2012, II) | 64 (85 − 21) |
AG (30) CG (34) |
AG (M 21; F 9) CG (M 20; F 14) |
AG: 53.5 ± 7.8 CG: 53.85 ± 7.2 | 12 |
|
Mazzocca et al. [68] (2017, II) | 58 (73 − 15) |
AG (31) CG (27) |
AG (M 21; F 10) CG (M 19; F 8) |
AG: 55 ± 8 CG: 54 ± 7 | 12 |
|
Raschhofer et al. [69] (2017, II) | 29 (30–1) |
AG (14) CG (15) |
AG (M 10; F 4) CG (M 9; F 6) |
AG: 54.4 ± 3.0 CG: 58.4 ± 3.5 | 6 |
|
Sheps et al. [78] (2015, II) | 165 (189–24) |
AG (97) CG (92) |
AG (M 57; F 40) CG (M 58; F 34) |
AG: 55.4 CG: 54.9 | 24 |
|
Sheps et al. [79] (2019, I) | 206 (206 -0) |
AG (103) CG (103) |
AG (M 65; F 38) CG (M 66; F 37) |
AG: 55.5 CG: 56.2 | 24 |
|
Tirefort et al. [80] (2019, I) | 80 (80 − 0) |
AG (40) CG (40) |
AG (M 23; F 17) CG (M 14; F 26) |
AG: 53.5 ± 11.0 CG: 54.7 ± 8.7 | 6 |